Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
Submitted by
admin
on September 18, 2012 - 11:09am
Source:
Seeking Alpha
News Tags:
PDL Biopharma
Novartis
Seattle Genetics
Pfizer
JNJ
Eli Lilly
GSK
Bristol-Myers Squibb
Headline:
PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
Do Not Allow Advertisers to Use My Personal information
